Literature DB >> 8910419

Silencing of the constitutive activity of the dopamine D1B receptor. Reciprocal mutations between D1 receptor subtypes delineate residues underlying activation properties.

S Charpentier1, K R Jarvie, D M Severynse, M G Caron, M Tiberi.   

Abstract

Recently, we have shown that the dopamine D1B/D5 receptor displays binding and coupling properties that are reminiscent of those of the constitutively activated G protein-coupled receptors when compared with the related D1A/D1 receptor subtype (Tiberi, M., and Caron, M. G. (1994) J. Biol. Chem. 269, 27925-27931). The carboxyl-terminal region of the third cytoplasmic loop of several G protein-coupled receptors has been demonstrated to be important for the regulation of the equilibrium between inactive and active receptor conformations. In this cytoplasmic region, the primary structure of dopamine D1A and D1B receptors differs by only two residues: Phe264/Arg266 are present in D1A receptor compared with Ile288/Lys290 in the D1B receptor. To investigate whether these structural differences could account for the distinct binding and coupling properties of these dopamine receptor subtypes, we swapped the variant residues located in the carboxyl-terminal region by site-directed mutagenesis. The exchange of the D1A receptor residue Phe264 by the D1B receptor counterpart isoleucine led to a D1A receptor mutant exhibiting D1B-like constitutive properties. In contrast, substitution of D1B receptor Ile288 by the D1A receptor counterpart phenylalanine resulted in a loss of constitutive activation of the D1B receptor with binding and coupling properties similar to the D1A receptor. The Arg/Lys substitution had no effect on the function of either receptor. These results demonstrate that the carboxyl-terminal region, and in particular residue Ile288, is a major determinant of the constitutive activity of the dopamine D1B receptor. Moreover, these results establish that not only can agonist-independent activity of a receptor be induced, but when given the appropriate mutation, it can be reversed or silenced.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910419     DOI: 10.1074/jbc.271.45.28071

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.

Authors:  Jonathan Chetrit; Anne Taupignon; Lionel Froux; Stephanie Morin; Rabia Bouali-Benazzouz; Frédéric Naudet; Nabila Kadiri; Christian E Gross; Bernard Bioulac; Abdelhamid Benazzouz
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 3.  Review: amino acid domains involved in constitutive activation of G-protein-coupled receptors.

Authors:  P J Pauwels; T Wurch
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

Review 4.  Direct receptor cross-talk can mediate the modulation of excitatory and inhibitory neurotransmission by dopamine.

Authors:  Frank J S Lee; Yu-tian Wang; Fang Liu
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice.

Authors:  Xiaoyan Wang; Yingjin Luo; Crisanto S Escano; Zhiwei Yang; Laureano Asico; Hewang Li; John E Jones; Ines Armando; Quansheng Lu; David R Sibley; Gilbert M Eisner; Pedro A Jose
Journal:  Hypertension       Date:  2010-04-19       Impact factor: 10.190

6.  Sorting nexin 1 loss results in increased oxidative stress and hypertension.

Authors:  Jian Yang; Laureano D Asico; Amber L Beitelshees; Jun B Feranil; Xiaoyan Wang; John E Jones; Ines Armando; Santiago G Cuevas; Gary L Schwartz; John G Gums; Arlene B Chapman; Stephen T Turner; Eric Boerwinkle; Rhonda M Cooper-DeHoff; Julie A Johnson; Robin A Felder; Edward J Weinman; Chunyu Zeng; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-15       Impact factor: 5.191

7.  Comparison of naltrexone, 6alpha-naltrexol, and 6beta-naltrexol in morphine-dependent and in nondependent rhesus monkeys.

Authors:  Jun-Xu Li; Lance R McMahon; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2007-09-16       Impact factor: 4.530

8.  D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance.

Authors:  Jérôme Baufreton; Maurice Garret; Alicia Rivera; Adélaïda de la Calle; François Gonon; Bernard Dufy; Bernard Bioulac; Anne Taupignon
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

9.  A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra.

Authors:  Buket Dalgic; Odul Egritas; Sinan Sari; Laurence Cuisset
Journal:  Pediatr Nephrol       Date:  2007-05-08       Impact factor: 3.714

10.  Dopamine modulates the plasticity of mechanosensory responses in Caenorhabditis elegans.

Authors:  Suparna Sanyal; Richard F Wintle; Katie S Kindt; William M Nuttley; Rokhand Arvan; Paul Fitzmaurice; Eve Bigras; David C Merz; Terence E Hébert; Derek van der Kooy; William R Schafer; Joseph G Culotti; Hubert H M Van Tol
Journal:  EMBO J       Date:  2004-01-22       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.